| cohort1 (N=81) |
cohort2 (N=52) |
P-value | |
|---|---|---|---|
| Sex | |||
| female | 7 (8.6%) | 6 (11.5%) | 0.803 |
| male | 74 (91.4%) | 46 (88.5%) | |
| Age (years) | |||
| Mean (SD) | 63.5 (11.3) | 62.5 (7.32) | 0.902 |
| Median [Min, Max] | 65.0 [2.00, 80.0] | 62.5 [47.0, 76.0] | |
| Smoking_history | |||
| No | 21 (25.9%) | 10 (19.2%) | 0.47 |
| Yes | 53 (65.4%) | 38 (73.1%) | |
| Missing | 7 (8.6%) | 4 (7.7%) | |
| Stage | |||
| III | 4 (4.9%) | 6 (11.5%) | 0.166 |
| IV | 12 (14.8%) | 11 (21.2%) | |
| IVa | 19 (23.5%) | 15 (28.8%) | |
| IVb | 46 (56.8%) | 20 (38.5%) | |
| 治疗线数 | |||
| 二线治疗 | 5 (6.2%) | 5 (9.6%) | 0.691 |
| 一线治疗 | 76 (93.8%) | 47 (90.4%) | |
| Best_response | |||
| PD | 1 (1.2%) | 1 (1.9%) | 0.585 |
| PR | 38 (46.9%) | 22 (42.3%) | |
| SD | 23 (28.4%) | 20 (38.5%) | |
| Missing | 19 (23.5%) | 9 (17.3%) | |
| clinical.benefit | |||
| DCB | 65 (80.2%) | 43 (82.7%) | 1 |
| NDB | 15 (18.5%) | 9 (17.3%) | |
| Missing | 1 (1.2%) | 0 (0%) |